These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 26280405)
21. A score to predict short-term risk of COPD exacerbations (SCOPEX). Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896 [TBL] [Abstract][Full Text] [Related]
22. Occurrence of respiratory symptoms in persons with restrictive ventilatory impairment compared with persons with chronic obstructive pulmonary disease: The PLATINO study. Nonato NL; Nascimento OA; Padilla RP; de Oca MM; Tálamo C; Valdivia G; Lisboa C; López MV; Celli B; Menezes AM; Jardim JR Chron Respir Dis; 2015 Aug; 12(3):264-73. PubMed ID: 26041119 [TBL] [Abstract][Full Text] [Related]
23. Effect of tele health care on exacerbations and hospital admissions in patients with chronic obstructive pulmonary disease: a randomized clinical trial. Ringbæk T; Green A; Laursen LC; Frausing E; Brøndum E; Ulrik CS Int J Chron Obstruct Pulmon Dis; 2015; 10():1801-8. PubMed ID: 26366072 [TBL] [Abstract][Full Text] [Related]
24. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715 [TBL] [Abstract][Full Text] [Related]
25. Validation of the French version of the Leicester Cough Questionnaire in chronic obstructive pulmonary disease. Reychler G; Schinckus M; Fremault A; Liistro G; Pieters T Chron Respir Dis; 2015 Nov; 12(4):313-9. PubMed ID: 26346891 [TBL] [Abstract][Full Text] [Related]
26. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Karadag F; Karul AB; Cildag O; Yilmaz M; Ozcan H Lung; 2008; 186(6):403-9. PubMed ID: 18807087 [TBL] [Abstract][Full Text] [Related]
27. Lobe-based computed tomography assessment of airway diameter, airway or vessel number, and emphysema extent in relation to the clinical outcomes of COPD. Kurashima K; Takaku Y; Hoshi T; Kanauchi T; Nakamoto K; Takayanagi N; Yanagisawa T; Sugita Y; Kawabata Y Int J Chron Obstruct Pulmon Dis; 2015; 10():1027-33. PubMed ID: 26082626 [TBL] [Abstract][Full Text] [Related]
28. Assessing the effectiveness of the COPD Assessment Test (CAT) to evaluate COPD severity and exacerbation rates. Varol Y; Ozacar R; Balci G; Usta L; Taymaz Z COPD; 2014 Apr; 11(2):221-5. PubMed ID: 24111793 [TBL] [Abstract][Full Text] [Related]
29. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease. Yetkin O; Gunen H Clin Respir J; 2008 Jan; 2(1):36-40. PubMed ID: 20298302 [TBL] [Abstract][Full Text] [Related]
30. Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary disease. Desai H; Eschberger K; Wrona C; Grove L; Agrawal A; Grant B; Yin J; Parameswaran GI; Murphy T; Sethi S Ann Am Thorac Soc; 2014 Mar; 11(3):303-9. PubMed ID: 24423399 [TBL] [Abstract][Full Text] [Related]
31. Relationship between exhaled nitric oxide and treatment response in COPD patients with exacerbations. Antus B; Barta I; Horvath I; Csiszer E Respirology; 2010 Apr; 15(3):472-7. PubMed ID: 20210889 [TBL] [Abstract][Full Text] [Related]
32. A longitudinal assessment of sleep variables during exacerbations of chronic obstructive pulmonary disease. Vanaparthy R; Mota P; Khan R; Ehsan M; Qureshi A; ZuWallack R; Leidy N Chron Respir Dis; 2015 Nov; 12(4):299-304. PubMed ID: 26033837 [TBL] [Abstract][Full Text] [Related]
33. Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD. Rebelo P; Oliveira A; Paixão C; Valente C; Andrade L; Marques A Int J Chron Obstruct Pulmon Dis; 2020; 15():201-212. PubMed ID: 32099345 [TBL] [Abstract][Full Text] [Related]
34. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD. Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105 [TBL] [Abstract][Full Text] [Related]
36. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. Casanova C; de Torres JP; Aguirre-Jaíme A; Pinto-Plata V; Marin JM; Cordoba E; Baz R; Cote C; Celli BR Am J Respir Crit Care Med; 2011 Nov; 184(9):1015-21. PubMed ID: 21836135 [TBL] [Abstract][Full Text] [Related]
37. Impact of chronic obstructive pulmonary diseases on outcomes and hospital days after percutaneous coronary intervention. Zhang JW; Zhou YJ; Yang Q; Yang SW; Nie B; Xu XH Angiology; 2013 Aug; 64(6):430-4. PubMed ID: 22942128 [TBL] [Abstract][Full Text] [Related]
38. Cognitive function in chronic obstructive pulmonary disease: relationship to global initiative for chronic obstructive lung disease 2011 categories. Tulek B; Atalay NB; Yildirim G; Kanat F; Süerdem M Respirology; 2014 Aug; 19(6):873-80. PubMed ID: 24935516 [TBL] [Abstract][Full Text] [Related]
39. The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation. Agapakis DI; Massa EV; Hantzis I; Maraslis S; Alexiou E; Imprialos KP; Damianidou M; Satsoglou E Respir Care; 2016 Jan; 61(1):44-9. PubMed ID: 26604328 [TBL] [Abstract][Full Text] [Related]
40. Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease. Chen CZ; Ou CY; Yu CH; Yang SC; Chang HY; Hsiue TR J Am Geriatr Soc; 2015 Feb; 63(2):244-50. PubMed ID: 25641518 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]